Primary antiphospholipid syndrome
MONDO:0005204An antiphospholipid syndrome that occurs as an isolated disorder.
39 clinical trials for this condition and its sub-types, 4 tagged with Primary antiphospholipid syndrome itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Part of
-
Could a cancer drug tame rare clotting disorder?
Disease control Recruiting nowThis study tests whether daratumumab, a drug used for certain cancers, is safe for people with antiphospholipid syndrome (APS), an autoimmune disorder that raises blood clot risk. Up to 22 adults will receive weekly infusions for 8 weeks at different doses. The main goal is to ch…
Phase 1/2 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
New drug trial aims to tame rare clotting disorder
Disease control Recruiting nowThis study tests the safety of an experimental drug called anifrolumab in 20 adults with antiphospholipid syndrome (APS), a condition that raises the risk of blood clots and pregnancy complications. Participants receive weekly injections of the drug for up to 52 weeks, alongside …
Phase 2 • Sponsor: National and Kapodistrian University of Athens • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC